Diagnosis & Treatment

This guide has been written with the aim of developing the knowledge, awareness and skills of primary healthcare providers. Primary healthcare providers can play an important role in tuberculosis control through early detection of the disease, referral for treatment and involvement in directly observed therapy. This document is particularly relevant to primary healthcare providers in the countries of Eastern Europe, the Baltic States and the Commonwealth of Independent States (CIS). It is available in both Russian and English.

This material is available on-line only.

English (1.8 MB)Russian (1.8 MB)

This video/slide presentation provides a comprehensive overview of the "Standards of Care for Tuberculosis Disease and Latent Tuberculosis Infection" from the NJ Department of Health and Senior Services. Additionally, it clarifies the role of the community provider in concert with the State's Tuberculosis Program. This program can be viewed in parts or all at once. It has been accredited for continuing medical and nursing education credits.

Web Presentation

The most current TB treatment guidelines state that frequent monitoring of a patient's treatment regimen and response to treatment is critical and can be accomplished through use of a drug-o-gram. This electronic resource provides an interface for entering patient data to create a drug-o-gram. It includes a user's guide with instructions and teaching points.

For technical assistance with the product, please contact Anita Khilall at khilalan@umdnj.edu or at (973) 972-0979.

YOUR FEEDBACK IS IMPORTANT TO US! Please take some time to answer a few questions based on your use of the Drug-O-Gram.

View PDF (200 KB)Download (226 KB)

This pocket-sized drug treatment card for clinicians provides information on diagnosis of latent tuberculosis infection and therapy options and recommendations for infected patients.

View PDF (717 KB)Order Now

This resource will provide health departments with the ability to identify healthcare facilities in the community where targeted TB testing and treatment of LTBI are likely to be most successful and efficient. Used in conjunction with another product, Identifying Missed Opportunities for Preventing TB, health departments should be able to make a compelling case for strengthening activities in specific target facilities in the community.

This material is available on-line only.

View PDF (931 KB)

This scientific monograph, which was updated in 2008, discusses targeted tuberculin skin testing for latent TB infection as a strategic component of TB control. Specifically addressed are how to administer and interpret the tuberculin skin test with information about the test's specificity and sensitivity. There is also information about the QuantiFERON®- TB Gold In-Tube test and tuberculin sensitivity with mycobacteria other than M. tuberculosis. This monograph is certified for continuing medical and nursing education through the completion of a post-test and evaluation located at the end of the document.

View PDF (1 MB)Order Now

This online version of the scientific monograph of the same title, discusses targeted tuberculin skin testing for latent TB infection as a strategic component of TB control. Specifically addressed are how to administer and interpret the tuberculin skin test with information about the test's specificity and sensitivity. There is also information about the QuantiFERON®-TB Gold In-Tube test and tuberculin sensitivity with mycobacteria other than M. tuberculosis. This monograph is certified for continuing medical and nursing education through the completion of a post-test and evaluation located at the end of the document.

Web Presentation

This manual is to be used with active TB cases to document the extent to which cases could have been prevented. The methodology identifies providers who served the patient prior to the TB diagnosis and points at which the provider failed to carry out targeted testing and treatment of LTBI recommendations. A questionnaire supplementing routine TB surveillance data is also included.

This material is available on-line only.

View PDF (3.9 MB)

This wallet-sized card provides LTBI patients with a permanent record of their tuberculin skin test, chest x-ray and treatment status. Patients can carry the card at all times and show it whenever they are seen by a new healthcare provider. This card is available in PDF format and MS Word and is in multiple languages.

This material is available on-line only.

View PDF (4.1 MB)

These 3 multimedia videos cover screening, diagnosis and treatment of Latent Tuberculosis Infection. The multimedia videos are targeted to community health providers, including those working at Federally Qualified Health Centers. The videos range from 6 to 15 minutes, and seamlessly incorporate images, voice and text. The videos can be viewed from a computer, laptop, smartphone or tablet, whether you are at home, work or on the go. Resources and transcripts are also available.

 To view the videos, visit:
http://www.umdnj.edu/ntbcweb/products/ltbimultimedia.htm

This material is available on-line only.

This handbook is a resource for primary care providers. Topics include targeted testing, risk assessment, and treatment of LTBI in children and adolescents. Originally developed in 2004, this product was updated in 2009 to include the most recent recommendations found in the American Academy of Pediatrics 2009 edition of the Report of the Committee on Infectious Diseases (Red Book).

View PDF (468 KB) Order Now

Infusion therapy offers an important treatment option for multi-drug resistant tuberculosis (MDR-TB) when long-term injectable medications are required. This resource provides practical guidance relating to the proper use of ambulatory infusion therapy for the treatment of MDR-TB. The guide offers a rationale for providing outpatient infusion therapy for MDR-TB in a clinic setting and describes how to organize the clinic to provide the therapy. In addition, it contains a wall chart, which summarizes the daily tasks for providing infusion therapy.

This material is available on-line only.

View PDF (4.4 MB)Wallchart PDF (40 KB)

This handbook has been prepared for school nurses who may be responsible for implementing tuberculin testing programs in their schools or working in collaboration with community providers in both the public and private sectors to manage the care of a child with tuberculosis (TB) disease or latent TB infection (LTBI).

View PDF (625 KB)Order Now

This fact sheet is intended as a convenient but not comprehensive reference for managing the care of HIV-infected patients with drug-susceptible TB. It provides basic principles of treatment including drug interactions, oversight of medical care, and staggering of drugs in treatment naive, co-infected patients. A more detailed pocket card on treatment is due later this year.

View PDF (1.5 MB)

This pocket-size drug treatment card for clinicians provides information on the standard therapy for active tuberculosis disease, including dosages, daily and intermittent regimens, side effects, treatment information and visual depictions of first-line medications.

View PDF (1.5 MB)Order Now

This pocket-size drug treatment card for clinicians provides information on the standard anti-tuberculosis therapy for active disease in children, including dosages, daily and intermittent regimens, side effects, treatment information and visual depictions of first-line medications.

View PDF (1.5 MB)Order Now